TrialPanorama/Dataset huggingface dataset:
Please select the arm or intervention descriptions that belong to the clinical trial below.
Title: Monteleukast Versus Inhaled Mometasone for Treatment of Otitis Media With Effusion in Children
Brief Summary: Otitis media is one of the most common infections among children and is a complication in about 30% of common colds. The most common complication of acute otitis media is otitis media with effusion. Some studies have reported the effects of montelukast and mometasone nasal spray in treatment of otitis media with effusion. However, current information is inadequate in this issue. The aim of this study was to compare the effectiveness of montelukast and mometasone nasal spray in treatment of otitis media with effusion in children attending Koodakan hospital in Bandar Abbas, Iran.


Options:
A: Arm Label: Wait and watch (Group D); Type: NO_INTERVENTION; Interventions: N/A | Arm Label: Mometasone spray (Group B); Type: EXPERIMENTAL; Interventions: Drug: Mometasone 50 Mcg/Inh Nasal Spray | Arm Label: antibiotic + histaminic + oxymetazoline drops (Group A); Type: EXPERIMENTAL; Interventions: Drug: Antibiotics + Antihistamine (levocetirizine) + Nasal decongestants (Oxymetazoline 0.025%) | Arm Label: Oral steroid (Group C); Type: EXPERIMENTAL; Interventions: Drug: Steroid Drug (prednisolone) | Intervention Type: DRUG; Name: Mometasone 50 Mcg/Inh Nasal Spray; Assigned to Arm(s): Mometasone spray (Group B) | Intervention Type: DRUG; Name: Antibiotics + Antihistamine (levocetirizine) + Nasal decongestants (Oxymetazoline 0.025%); Assigned to Arm(s): antibiotic + histaminic + oxymetazoline drops (Group A) | Intervention Type: DRUG; Name: Steroid Drug (prednisolone); Assigned to Arm(s): Oral steroid (Group C)
B: Arm Label: Ventilation tube treatment; Type: EXPERIMENTAL; Interventions: Device: Ventilation tube treatment | Arm Label: Conservative treatment; Type: NO_INTERVENTION; Interventions: N/A | Intervention Type: DEVICE; Name: Ventilation tube treatment; Assigned to Arm(s): Ventilation tube treatment
C: Intervention Type: PROCEDURE; Name: Insertion of tympanostomy tubes; Assigned to Arm(s): N/A
D: Arm Label: Montelukast; Type: EXPERIMENTAL; Interventions: Drug: Monteleukast | Arm Label: Mometasone; Type: ACTIVE_COMPARATOR; Interventions: Drug: Mometasone | Arm Label: Control; Type: NO_INTERVENTION; Interventions: N/A | Intervention Type: DRUG; Name: Monteleukast; Assigned to Arm(s): Montelukast | Intervention Type: DRUG; Name: Mometasone; Assigned to Arm(s): Mometasone

Answer: D
Please select the arm or intervention descriptions that belong to the clinical trial below.
Title: Monteleukast Versus Inhaled Mometasone for Treatment of Otitis Media With Effusion in Children
Brief Summary: Otitis media is one of the most common infections among children and is a complication in about 30% of common colds. The most common complication of acute otitis media is otitis media with effusion. Some studies have reported the effects of montelukast and mometasone nasal spray in treatment of otitis media with effusion. However, current information is inadequate in this issue. The aim of this study was to compare the effectiveness of montelukast and mometasone nasal spray in treatment of otitis media with effusion in children attending Koodakan hospital in Bandar Abbas, Iran.


Options:
A: Arm Label: Ventilation tube treatment; Type: EXPERIMENTAL; Interventions: Device: Ventilation tube treatment | Arm Label: Conservative treatment; Type: NO_INTERVENTION; Interventions: N/A | Intervention Type: DEVICE; Name: Ventilation tube treatment; Assigned to Arm(s): Ventilation tube treatment
B: Arm Label: Triamcinolone acetonide; Type: ACTIVE_COMPARATOR; Interventions: Drug: Triamcinolone acetonide nasal spray | Arm Label: Placebo; Type: SHAM_COMPARATOR; Interventions: Drug: Placebo nasal spray | Intervention Type: DRUG; Name: Triamcinolone acetonide nasal spray; Assigned to Arm(s): Triamcinolone acetonide | Intervention Type: DRUG; Name: Placebo nasal spray; Assigned to Arm(s): Placebo
C: Arm Label: Montelukast; Type: EXPERIMENTAL; Interventions: Drug: Monteleukast | Arm Label: Mometasone; Type: ACTIVE_COMPARATOR; Interventions: Drug: Mometasone | Arm Label: Control; Type: NO_INTERVENTION; Interventions: N/A | Intervention Type: DRUG; Name: Monteleukast; Assigned to Arm(s): Montelukast | Intervention Type: DRUG; Name: Mometasone; Assigned to Arm(s): Mometasone
D: Arm Label: Wait and watch (Group D); Type: NO_INTERVENTION; Interventions: N/A | Arm Label: Mometasone spray (Group B); Type: EXPERIMENTAL; Interventions: Drug: Mometasone 50 Mcg/Inh Nasal Spray | Arm Label: antibiotic + histaminic + oxymetazoline drops (Group A); Type: EXPERIMENTAL; Interventions: Drug: Antibiotics + Antihistamine (levocetirizine) + Nasal decongestants (Oxymetazoline 0.025%) | Arm Label: Oral steroid (Group C); Type: EXPERIMENTAL; Interventions: Drug: Steroid Drug (prednisolone) | Intervention Type: DRUG; Name: Mometasone 50 Mcg/Inh Nasal Spray; Assigned to Arm(s): Mometasone spray (Group B) | Intervention Type: DRUG; Name: Antibiotics + Antihistamine (levocetirizine) + Nasal decongestants (Oxymetazoline 0.025%); Assigned to Arm(s): antibiotic + histaminic + oxymetazoline drops (Group A) | Intervention Type: DRUG; Name: Steroid Drug (prednisolone); Assigned to Arm(s): Oral steroid (Group C)

Answer: C
Please select the arm or intervention descriptions that belong to the clinical trial below.
Title: Monteleukast Versus Inhaled Mometasone for Treatment of Otitis Media With Effusion in Children
Brief Summary: Otitis media is one of the most common infections among children and is a complication in about 30% of common colds. The most common complication of acute otitis media is otitis media with effusion. Some studies have reported the effects of montelukast and mometasone nasal spray in treatment of otitis media with effusion. However, current information is inadequate in this issue. The aim of this study was to compare the effectiveness of montelukast and mometasone nasal spray in treatment of otitis media with effusion in children attending Koodakan hospital in Bandar Abbas, Iran.


Options:
A: Arm Label: Triamcinolone acetonide; Type: ACTIVE_COMPARATOR; Interventions: Drug: Triamcinolone acetonide nasal spray | Arm Label: Placebo; Type: SHAM_COMPARATOR; Interventions: Drug: Placebo nasal spray | Intervention Type: DRUG; Name: Triamcinolone acetonide nasal spray; Assigned to Arm(s): Triamcinolone acetonide | Intervention Type: DRUG; Name: Placebo nasal spray; Assigned to Arm(s): Placebo
B: Arm Label: Ventilation tube treatment; Type: EXPERIMENTAL; Interventions: Device: Ventilation tube treatment | Arm Label: Conservative treatment; Type: NO_INTERVENTION; Interventions: N/A | Intervention Type: DEVICE; Name: Ventilation tube treatment; Assigned to Arm(s): Ventilation tube treatment
C: Intervention Type: PROCEDURE; Name: Insertion of tympanostomy tubes; Assigned to Arm(s): N/A
D: Arm Label: Montelukast; Type: EXPERIMENTAL; Interventions: Drug: Monteleukast | Arm Label: Mometasone; Type: ACTIVE_COMPARATOR; Interventions: Drug: Mometasone | Arm Label: Control; Type: NO_INTERVENTION; Interventions: N/A | Intervention Type: DRUG; Name: Monteleukast; Assigned to Arm(s): Montelukast | Intervention Type: DRUG; Name: Mometasone; Assigned to Arm(s): Mometasone

Answer: D
Please select the arm or intervention descriptions that belong to the clinical trial below.
Title: Monteleukast Versus Inhaled Mometasone for Treatment of Otitis Media With Effusion in Children
Brief Summary: Otitis media is one of the most common infections among children and is a complication in about 30% of common colds. The most common complication of acute otitis media is otitis media with effusion. Some studies have reported the effects of montelukast and mometasone nasal spray in treatment of otitis media with effusion. However, current information is inadequate in this issue. The aim of this study was to compare the effectiveness of montelukast and mometasone nasal spray in treatment of otitis media with effusion in children attending Koodakan hospital in Bandar Abbas, Iran.


Options:
A: Arm Label: Montelukast; Type: EXPERIMENTAL; Interventions: Drug: Monteleukast | Arm Label: Mometasone; Type: ACTIVE_COMPARATOR; Interventions: Drug: Mometasone | Arm Label: Control; Type: NO_INTERVENTION; Interventions: N/A | Intervention Type: DRUG; Name: Monteleukast; Assigned to Arm(s): Montelukast | Intervention Type: DRUG; Name: Mometasone; Assigned to Arm(s): Mometasone
B: Arm Label: Triamcinolone acetonide; Type: ACTIVE_COMPARATOR; Interventions: Drug: Triamcinolone acetonide nasal spray | Arm Label: Placebo; Type: SHAM_COMPARATOR; Interventions: Drug: Placebo nasal spray | Intervention Type: DRUG; Name: Triamcinolone acetonide nasal spray; Assigned to Arm(s): Triamcinolone acetonide | Intervention Type: DRUG; Name: Placebo nasal spray; Assigned to Arm(s): Placebo
C: Arm Label: Ventilation tube treatment; Type: EXPERIMENTAL; Interventions: Device: Ventilation tube treatment | Arm Label: Conservative treatment; Type: NO_INTERVENTION; Interventions: N/A | Intervention Type: DEVICE; Name: Ventilation tube treatment; Assigned to Arm(s): Ventilation tube treatment
D: Arm Label: Wait and watch (Group D); Type: NO_INTERVENTION; Interventions: N/A | Arm Label: Mometasone spray (Group B); Type: EXPERIMENTAL; Interventions: Drug: Mometasone 50 Mcg/Inh Nasal Spray | Arm Label: antibiotic + histaminic + oxymetazoline drops (Group A); Type: EXPERIMENTAL; Interventions: Drug: Antibiotics + Antihistamine (levocetirizine) + Nasal decongestants (Oxymetazoline 0.025%) | Arm Label: Oral steroid (Group C); Type: EXPERIMENTAL; Interventions: Drug: Steroid Drug (prednisolone) | Intervention Type: DRUG; Name: Mometasone 50 Mcg/Inh Nasal Spray; Assigned to Arm(s): Mometasone spray (Group B) | Intervention Type: DRUG; Name: Antibiotics + Antihistamine (levocetirizine) + Nasal decongestants (Oxymetazoline 0.025%); Assigned to Arm(s): antibiotic + histaminic + oxymetazoline drops (Group A) | Intervention Type: DRUG; Name: Steroid Drug (prednisolone); Assigned to Arm(s): Oral steroid (Group C)

Answer: A
Please select the arm or intervention descriptions that belong to the clinical trial below.
Title: Monteleukast Versus Inhaled Mometasone for Treatment of Otitis Media With Effusion in Children
Brief Summary: Otitis media is one of the most common infections among children and is a complication in about 30% of common colds. The most common complication of acute otitis media is otitis media with effusion. Some studies have reported the effects of montelukast and mometasone nasal spray in treatment of otitis media with effusion. However, current information is inadequate in this issue. The aim of this study was to compare the effectiveness of montelukast and mometasone nasal spray in treatment of otitis media with effusion in children attending Koodakan hospital in Bandar Abbas, Iran.


Options:
A: Arm Label: Triamcinolone acetonide; Type: ACTIVE_COMPARATOR; Interventions: Drug: Triamcinolone acetonide nasal spray | Arm Label: Placebo; Type: SHAM_COMPARATOR; Interventions: Drug: Placebo nasal spray | Intervention Type: DRUG; Name: Triamcinolone acetonide nasal spray; Assigned to Arm(s): Triamcinolone acetonide | Intervention Type: DRUG; Name: Placebo nasal spray; Assigned to Arm(s): Placebo
B: Arm Label: Montelukast; Type: EXPERIMENTAL; Interventions: Drug: Monteleukast | Arm Label: Mometasone; Type: ACTIVE_COMPARATOR; Interventions: Drug: Mometasone | Arm Label: Control; Type: NO_INTERVENTION; Interventions: N/A | Intervention Type: DRUG; Name: Monteleukast; Assigned to Arm(s): Montelukast | Intervention Type: DRUG; Name: Mometasone; Assigned to Arm(s): Mometasone
C: Intervention Type: PROCEDURE; Name: adenoidectomy and tymapanostomy; Assigned to Arm(s): N/A
D: Arm Label: 1; Type: ACTIVE_COMPARATOR; Interventions: Drug: Amoxycillin | Arm Label: 2; Type: PLACEBO_COMPARATOR; Interventions: Drug: Placebo equivalent to amoxycillin | Intervention Type: DRUG; Name: Amoxycillin; Assigned to Arm(s): 1 | Intervention Type: DRUG; Name: Placebo equivalent to amoxycillin; Assigned to Arm(s): 2

Answer: B
Please select the arm or intervention descriptions that belong to the clinical trial below.
Title: Safety and Efficacy of Fibrinogen Concentrate in Aortic Arch Surgery Involving Moderate Hypothermic Circulatory Arrest
Brief Summary: Bleeding is a common complication of cardiac surgery, especially aortic arch surgery involving moderate hypothermic circulatory arrest. Fibrinogen concentrate is increasingly used to treat coagulopathic bleeding in cardiac surgery, although its effectiveness and safety are unknown.

Fibrinogen concentrate was administered to 54 patients when the fibrinogen level was below 1.5 g/L after protamine reversal. Additionally, 30 patients were enrolled as the non-FC-treated group.


Options:
A: Arm Label: Placebo; Type: PLACEBO_COMPARATOR; Interventions: Drug: Fibrinogen | Arm Label: Study drug; Type: EXPERIMENTAL; Interventions: Drug: Fibrinogen | Intervention Type: DRUG; Name: Fibrinogen; Assigned to Arm(s): Placebo, Study drug
B: Arm Label: Albumin; Type: PLACEBO_COMPARATOR; Interventions: Drug: Human albumin (Placebo) | Arm Label: Haemocomplettan® P; Type: EXPERIMENTAL; Interventions: Drug: Haemocomplettan® P | Intervention Type: DRUG; Name: Haemocomplettan® P; Assigned to Arm(s): Haemocomplettan® P | Intervention Type: DRUG; Name: Human albumin (Placebo); Assigned to Arm(s): Albumin
C: Arm Label: FXIII17.5IU/Kg; Type: EXPERIMENTAL; Interventions: Drug: catridecacog | Arm Label: FXIII35IU/Kg; Type: EXPERIMENTAL; Interventions: Drug: catridecacog | Arm Label: Placebo; Type: PLACEBO_COMPARATOR; Interventions: Drug: placebo | Intervention Type: DRUG; Name: catridecacog; Assigned to Arm(s): FXIII17.5IU/Kg | Intervention Type: DRUG; Name: catridecacog; Assigned to Arm(s): FXIII35IU/Kg | Intervention Type: DRUG; Name: placebo; Assigned to Arm(s): Placebo
D: Arm Label: fibrinogen concentrate-treated group; Type: EXPERIMENTAL; Interventions: Drug: fibrinogen concentrate | Arm Label: non-fibrinogen concentrate-treated group; Type: NO_INTERVENTION; Interventions: N/A | Intervention Type: DRUG; Name: fibrinogen concentrate; Assigned to Arm(s): fibrinogen concentrate-treated group

Answer: D
Please select the arm or intervention descriptions that belong to the clinical trial below.
Title: Evaluation of Healing at Molar Extraction Sites With and Without Ridge Preservation
Brief Summary: Following tooth extraction ridge preservation procedure have been suggested to limit bone resorptive dimensional changes to facilitate prospective implant placement. While this is particularly true for anterior teeth, no evidence is available to establish clinical guidelines in posterior sites, i.e. following molar extraction.

This research project will answer the following question:

What are the dimensional changes of the hard and soft tissues encountered following molar extractions with and without ridge preservation?


Options:
A: Arm Label: Ridge preservation; Type: OTHER; Interventions: Procedure: Ridge preservation | Arm Label: No ridge preservation; Type: OTHER; Interventions: Procedure: Ridge preservation | Intervention Type: PROCEDURE; Name: Ridge preservation; Assigned to Arm(s): No ridge preservation, Ridge preservation
B: Arm Label: mineralized FDBA alone; Type: ACTIVE_COMPARATOR; Interventions: Device: Mineralized freeze-dried bone allograft alone | Arm Label: Combination of mineralized and deminieralized FDBA; Type: EXPERIMENTAL; Interventions: Device: Combination of Mineralized and demineralized freeze-dried bone allograft alone | Intervention Type: DEVICE; Name: Mineralized freeze-dried bone allograft alone; Assigned to Arm(s): mineralized FDBA alone | Intervention Type: DEVICE; Name: Combination of Mineralized and demineralized freeze-dried bone allograft alone; Assigned to Arm(s): Combination of mineralized and deminieralized FDBA
C: Arm Label: Combination 50% cortical/50% cancellous FDBA; Type: EXPERIMENTAL; Interventions: Device: 50% cortical/50% cancellous FDBA | Arm Label: 100% cortical FDBA; Type: ACTIVE_COMPARATOR; Interventions: Device: 100% cortical FDBA | Arm Label: 100% cancellous FDBA; Type: ACTIVE_COMPARATOR; Interventions: Device: 100% cancellous FDBA | Intervention Type: DEVICE; Name: 50% cortical/50% cancellous FDBA; Assigned to Arm(s): Combination 50% cortical/50% cancellous FDBA | Intervention Type: DEVICE; Name: 100% cortical FDBA; Assigned to Arm(s): 100% cortical FDBA | Intervention Type: DEVICE; Name: 100% cancellous FDBA; Assigned to Arm(s): 100% cancellous FDBA
D: Arm Label: Placing OSSIX-Plus in Extraction Site; Type: EXPERIMENTAL; Interventions: Device: OSSIX-Plus | Intervention Type: DEVICE; Name: OSSIX-Plus; Assigned to Arm(s): Placing OSSIX-Plus in Extraction Site

Answer: A
Please select the arm or intervention descriptions that belong to the clinical trial below.
Title: Treatment of Periodontal Disease in Patients With Acute Myocardial Infarction: Randomized Controlled Trial
Brief Summary: The main objective of this study is to evaluate the effect of treatment periodontal endothelium-dependent artery of the arm in patients with acute myocardial infarction with ST-segment elevation undergoing primary coronary intervention.


Options:
A: Arm Label: One-Stage Full-Mouth Disinfection; Type: EXPERIMENTAL; Interventions: Procedure: One-Stage Full-Mouth Disinfection | Arm Label: Periodontal care; Type: ACTIVE_COMPARATOR; Interventions: Procedure: Periodontal care | Intervention Type: PROCEDURE; Name: One-Stage Full-Mouth Disinfection; Assigned to Arm(s): One-Stage Full-Mouth Disinfection | Intervention Type: PROCEDURE; Name: Periodontal care; Assigned to Arm(s): Periodontal care
B: Arm Label: Comprehensive treatment; Type: EXPERIMENTAL; Interventions: Device: Subgingival scaling and root planing | Arm Label: Community treatment; Type: OTHER; Interventions: Device: Oral prophylaxis | Intervention Type: DEVICE; Name: Subgingival scaling and root planing; Assigned to Arm(s): Comprehensive treatment | Intervention Type: DEVICE; Name: Oral prophylaxis; Assigned to Arm(s): Community treatment
C: Intervention Type: BEHAVIORAL; Name: Nutritional and life style counseling; Assigned to Arm(s): N/A
D: Arm Label: periodontal treatment; Type: EXPERIMENTAL; Interventions: Procedure: periodontal treatment | Arm Label: Control Group.; Type: NO_INTERVENTION; Interventions: N/A | Intervention Type: PROCEDURE; Name: periodontal treatment; Assigned to Arm(s): periodontal treatment

Answer: D
Please select the arm or intervention descriptions that belong to the clinical trial below.
Title: Hybrid Controlled Trial to Implement Collaborative Care in General Mental Health
Brief Summary: This randomized program evaluation is undertaken in conjunction with the Department of Veterans Affairs (VA) Office of Mental Health Operations (OMHO) and the Quality Enhancement Research Initiative. It is designed to answer two related questions: (1) Can an evidence-based implementation strategy using the Center for Disease Control (CDC)'s Replicating Effective Programs plus External Facilitation (REP-F) enhance the adoption of team-based care in VA General Mental Health (GMH) Clinics, and (2) Does the establishment of such teams via implementation enhance Veterans' health status, satisfaction, and perceptions of care? The model for team-based care is the evidence-based Collaborative Chronic Care Model (CCM).

In conjunction with a nation-wide roll-out of the VA's Behavioral Health Interdisciplinary Program team (BHIP) initiative, the investigators have structured a randomized, controlled program evaluation to answer these questions. Specifically, using a stepped wedge design the investigators will randomize 9 VAMCs that have requested support in establishing a BHIP to 1 of 3 waves of REP-F support: immediate implementation support vs. 4-month vs. 8-month wait with dissemination of CCM materials (3 sites per wave). Fidelity and health outcome measures will be collected in a repeated measures design at 6-month intervals, and analyzed with general linear modeling.


Options:
A: Arm Label: 1; Type: EXPERIMENTAL; Interventions: Behavioral: Nurse case management | Arm Label: 2; Type: ACTIVE_COMPARATOR; Interventions: Behavioral: Usual care | Intervention Type: BEHAVIORAL; Name: Nurse case management; Assigned to Arm(s): 1 | Intervention Type: BEHAVIORAL; Name: Usual care; Assigned to Arm(s): 2
B: Arm Label: MOMCare intervention; Type: EXPERIMENTAL; Interventions: Behavioral: MOMCare | Arm Label: Care Plus; Type: NO_INTERVENTION; Interventions: N/A | Intervention Type: BEHAVIORAL; Name: MOMCare; Assigned to Arm(s): MOMCare intervention
C: Arm Label: Implementation Facilitation; Type: EXPERIMENTAL; Interventions: Other: Replicating Effective Programs plus External Facilitation | Arm Label: Educational Materials; Type: PLACEBO_COMPARATOR; Interventions: Other: Educational Materials | Intervention Type: OTHER; Name: Replicating Effective Programs plus External Facilitation; Assigned to Arm(s): Implementation Facilitation | Intervention Type: OTHER; Name: Educational Materials; Assigned to Arm(s): Educational Materials
D: Arm Label: Feedback Group; Type: EXPERIMENTAL; Interventions: Behavioral: Communication Feedback Form for Patients with Serious Illness | Arm Label: Comparison/Usual Care Group; Type: NO_INTERVENTION; Interventions: N/A | Intervention Type: BEHAVIORAL; Name: Communication Feedback Form for Patients with Serious Illness; Assigned to Arm(s): Feedback Group

Answer: C
Please select the arm or intervention descriptions that belong to the clinical trial below.
Title: Smokerface: A Photoaging Mobile App Promoting Poster Campaign for Preventing Smoking in Secondary Schools: Randomized Controlled Trial
Brief Summary: The purpose of this study is to determine whether photoaging mobile app promoting poster campaigns are effective to reduce smoking prevalence among adolescents in Germany. This is measured via questionnaire.


Options:
A: Arm Label: Intervention group; Type: EXPERIMENTAL; Interventions: Behavioral: Online Game | Arm Label: Control Group; Type: ACTIVE_COMPARATOR; Interventions: Behavioral: LGBTQ Resources | Intervention Type: BEHAVIORAL; Name: Online Game; Assigned to Arm(s): Intervention group | Intervention Type: BEHAVIORAL; Name: LGBTQ Resources; Assigned to Arm(s): Control Group
B: Arm Label: Intervention; Type: EXPERIMENTAL; Interventions: Behavioral: Teens Against Tobacco Use | Arm Label: Wait list control; Type: NO_INTERVENTION; Interventions: N/A | Intervention Type: BEHAVIORAL; Name: Teens Against Tobacco Use; Assigned to Arm(s): Intervention
C: Arm Label: Intervention; Type: EXPERIMENTAL; Interventions: Behavioral: Photoaging mobile app promoting poster campaign. | Arm Label: Control; Type: NO_INTERVENTION; Interventions: N/A | Intervention Type: BEHAVIORAL; Name: Photoaging mobile app promoting poster campaign.; Assigned to Arm(s): Intervention
D: Arm Label: This is Quitting; Type: EXPERIMENTAL; Interventions: Other: This is Quitting | Arm Label: Assessment only Control; Type: OTHER; Interventions: Other: Assessment only Control | Intervention Type: OTHER; Name: This is Quitting; Assigned to Arm(s): This is Quitting | Intervention Type: OTHER; Name: Assessment only Control; Assigned to Arm(s): Assessment only Control

Answer: C